Search Ontology:
ChEBI

6-alpha-maltosylglucose

Term ID
CHEBI:28191
Synonyms
  • (3R,4S,5S,6R)-6-[[(2S,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxymethyl]oxane-2,3,4,5-tetrol
  • (3R,4S,5S,6R)-6-[[(2S,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]oxymethyl]tetrahydropyran-2,3,4,5-tetrol
  • alpha-D-gluco-hexopyranosyl-(1->4)-alpha-D-gluco-hexopyranosyl-(1->6)-D-gluco-hexopyranose
  • alpha-D-glucopyranosyl-(1->4)-alpha-D-glucopyranosyl-(1->6)-D-glucopyranose
  • Glc(a1-4)Glc(a1-6)Glc
Definition
A glucotriose consisting of two α-D-glucopyranose residues and a D-glucopyranose residue joined in sequence by (1→4) and (1→6) glycosidic bonds.
References
  • glygen:G07348OG
  • glytoucan:G07348OG
  • hmdb:HMDB0039707
  • kegg.compound:C03367
  • kegg.glycan:G00389
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from 6-alpha-maltosylglucose
Phenotype where environments contain 6-alpha-maltosylglucose
Phenotype modified by environments containing 6-alpha-maltosylglucose
Phenotype affecting 6-alpha-maltosylglucose
Human Disease Model